Clinical Trial Update: Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports on Z-Endoxifen Hydrochloride being studied for estrogen receptor-positive breast cancer that is metastatic or locally recurre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Locally Recurrent Breast Cancer

Drugs mentioned

• Z-Endoxifen Hydrochloride (Z-Endoxifen hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HER2/Neu Positive, Recurrent Breast Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING